(Press-News.org) MINNEAPOLIS -- People who are depressed may have triple the risk of developing Parkinson's disease, according to a study published in the October 2, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
"Depression is linked in other studies to illnesses such as cancer and stroke," said study author Albert C. Yang, MD, PhD, with Taipei Veterans General Hospital in Taipei, Taiwan. "Our study suggests that depression may also be an independent risk factor for Parkinson's disease."
Researchers analyzed the medical records of 4,634 people with depression and 18,544 free of depression over 10 years. They also looked at the risk of Parkinson's disease after excluding people who were diagnosed with Parkinson's disease within two or five years following their depression diagnosis.
During the 10-year follow-up period, 66 people with depression, or 1.42 percent, and 97 without depression, or 0.52 percent, were diagnosed with Parkinson's disease. People with depression were 3.24 times more likely to develop Parkinson's disease than those without depression.
"Many questions remain, including whether depression is an early symptom of Parkinson's disease rather than an independent risk factor for the disease," Yang said. "Our study also found that depression and older age and having difficult-to-treat depression were significant risk factors as well."
###
The study was supported by Taipei Veterans General Hospital and Taiwan National Science Council.
To learn more about Parkinson's disease, please visit http://www.aan.com/patients.
The American Academy of Neurology, an association of more than 26,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, stroke, migraine, multiple sclerosis, brain injury, Parkinson's disease and epilepsy.
For more information about the American Academy of Neurology, visit http://www.aan.com or find us on Facebook, Twitter, Google+ and YouTube.
Media Contacts:
Rachel Seroka
rseroka@aan.com
(612) 928-6129
Michelle Uher
muher@aan.com
(612) 928-6120
Depression may increase your risk of Parkinson's disease
2013-10-03
ELSE PRESS RELEASES FROM THIS DATE:
Scientists find insect DEET receptors, develop safe alternatives to DEET
2013-10-03
RIVERSIDE, Calif. — Insects are repelled by N,N-diethyl-m-toluamide, also known as DEET. But exactly which olfactory receptors insects use to sense DEET has eluded scientists for long.
Now researchers at the University of California, Riverside have identified these DEET-detecting olfactory receptors that cause the repellency — a major breakthrough in the field of olfaction.
Further, the team of researchers has identified three safe compounds that mimic DEET and could one day be used to prevent the transmission of deadly vector-borne diseases such as malaria, dengue, ...
International study shows efficacy of new gastric cancer drug
2013-10-03
Barcelona, 03 October 2013. This international trial, published in The Lancet, is one of the largest phase III trials in second-line treatment of gastric cancer. Standard care for advanced gastric cancer, known as first-line treatment, is based on chemotherapy, but it only offers a median survival of 8 to 10 months.
The trial investigated the use of ramucirumab, an antibody developed to treat solid tumours that targets Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2), a key receptor in the angiogenesis process. It showed that ramucirumab effectively inhibits a ...
Newly identified biomarkers help predict outcome in deadly lung disease
2013-10-03
New Haven, Conn. – A Yale-led study has identified a gene expression profile that can predict outcomes and lead to better treatment for one of the most lethal lung diseases, idiopathic pulmonary fibrosis (IPF). The study appears in Science Translational Medicine.
IPF causes progressive scarring of the lungs, leading to cough, shortness of breath, and potentially death. In most cases, the cause cannot be identified, and there is no cure other than a lung transplant. While some patients experience a progressive course that leads to death within one to two years, others ...
Long-term cognitive impairment too common after critical illness
2013-10-03
Patients treated in intensive care units across the globe are entering their medical care with no evidence of cognitive impairment but oftentimes leaving with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer's disease (AD) that persists for at least a year, according to a Vanderbilt study published today in the New England Journal of Medicine.
The study, led by members of Vanderbilt's ICU Delirium and Cognitive Impairment Group, found that 74 percent of the 821 patients studied, all adults with respiratory failure, cardiogenic ...
High-dose statins reduce gum inflammation in heart disease patients
2013-10-03
WASHINGTON (Oct. 2, 2013) — Statins, commonly prescribed medications for lowering cholesterol, also reduced inflammation associated with gum disease in a new study published today in the Journal of the American College of Cardiology. The study suggests that steps taken to reduce gum disease may also reduce inflammation in the arteries and vice versa.
"Periodontal disease is characterized by chronic gum inflammation and affects approximately 50 percent of the U.S. adult population," said Ahmed Tawkol, MD, co-director of the Cardiac Imaging Trials Program at Massachusetts ...
McMaster lab develops new tuberculosis vaccine
2013-10-03
Hamilton, ON (Oct. 2, 2013) -- A tuberculosis vaccine developed at McMaster University offers new hopes for the global fight against tuberculosis.
"We are the first to have developed such a vaccine for tuberculosis," said Dr. Fiona Smaill, professor and chair of the Department of Pathology and Molecular Medicine of the Michael G. DeGroote School of Medicine at McMaster. She led the phase one clinical study published today in the journal Science Translational Medicine.
The vaccine, based on a genetically modified cold virus, was developed in the lab of Zhou Xing, professor ...
In spectrum of ACL injury treatment, new study reveals cost savings for those who need surgery
2013-10-03
Rosemont, Ill – In late summer and early fall when youth and college sports begin, it's a similar refrain: a star on the varsity basketball team tore her anterior cruciate ligament (ACL) and is out for the season after surgery. A college football game stopped as a defensive safety hobbles off the field with an ACL injury. Annually in the U.S., more than 200,000 ACL injuries are reported, often by active young adult and adolescent athletes, though they can occur at any age. Depending on the severity of the injury, treatment may include rehabilitation or surgery and rehabilitation, ...
Specialized intestinal cells cause some cases of Crohn's disease
2013-10-03
Scientists have discovered that Crohn's disease, the inflammatory bowel disorder, can originate from specialised intestinal cell type called Paneth cells. As such, they propose that small intestinal Crohn's disease might be a specific disorder of this cell type, providing a possible new target for treatments. The study, by researchers from the University of Cambridge and Harvard University, was published today in the journal Nature.
"If we are able to break down Crohn's disease into subsets by understanding the underlying mechanisms, which we have done here, we hope to ...
Red wine chemical remains effective against cancer after the body converts it
2013-10-03
A chemical found in red wine remains effective at fighting cancer even after the body's metabolism has converted it into other compounds.
This is an important finding in a new paper published in the journal Science Translational Medicine by Cancer Research UK-funded researchers at the University of Leicester's Department of Cancer Studies and Molecular Medicine.
The paper reveals that resveratrol – a compound extracted from the skins of red grapes – is not rendered ineffective once it is metabolised by the body.
This is an important development, as resveratrol is ...
Tears for fears
2013-10-03
Nocturnal animals need their noses to stay alive. Mice, among others, depend on their impressive olfactory powers to sniff out food or avoid danger in the dark.
Hard-wired to flee a predator or fight a mating rival in response to a whiff of urine, mice use a streamlined system that sends the sensory cue to neural centers in the brain that need only a few synapses to rapidly initiate the instinctive behavior. By comparison, the visual system on which humans rely to sense a threat must process many more variables, detecting the edges and colors and contrast of that looming ...